English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation Journal article
Chen, Jia Yue, Zhu, Qi, Cai, Cui Zan, Luo, Hai Bin, Lu, Jia Hong. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation[J]. Phytomedicine, 2022, 101, 154125.
Authors:  Chen, Jia Yue;  Zhu, Qi;  Cai, Cui Zan;  Luo, Hai Bin;  Lu, Jia Hong
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:6.7/6.2 | Submit date：2022/05/31
Alpha-synuclein (Α-syn)  Parkinson's Disease  Phosphodiesterase 4 Inhibitor  Protein Kinase a (Pka)  Ubiquitin-proteasome System (Ups)  
Roflupram, a Phosphodiesterase 4 Inhibitior, Suppresses Inflammasome Activation through Autophagy in Microglial Cells Journal article
You, Tingting, Cheng, Yufang, Zhong, Jiahong, Bi, Bingtian, Zeng, Bingqing, Zheng, Wenhua, Wang, Haitao, Xu, Jiangping. Roflupram, a Phosphodiesterase 4 Inhibitior, Suppresses Inflammasome Activation through Autophagy in Microglial Cells[J]. ACS CHEMICAL NEUROSCIENCE, 2017, 8(11), 2381-2392.
Authors:  You, Tingting;  Cheng, Yufang;  Zhong, Jiahong;  Bi, Bingtian;  Zeng, Bingqing; et al.
Favorite | TC[WOS]:34 TC[Scopus]:37  IF:4.1/4.3 | Submit date：2018/10/30
Phosphodiesterase 4  Roflupram  Autophagy  Inflammasome  Microglia  Neuroinflammation  
Roflupram, a Phosphodiesterase Inhibitior, Suppresses Inflammasome Activation through Autophagy in Microglial Cells Journal article
Zheng, W.. Roflupram, a Phosphodiesterase Inhibitior, Suppresses Inflammasome Activation through Autophagy in Microglial Cells[J]. ACS chemical neuroscience, 2017, 1-11.
Authors:  Zheng, W.
Favorite |   IF:4.1/4.3 | Submit date：2022/08/31
Phosphodiesterase 4  roflupram  autophagy  inflammasome  microglia  neuroinflammation